EUVIMEDEUVIMED entdecken
Crossref

β-Carboline derivatives are potent against Acute Myeloid Leukemia in vitro and in vivo

Maura Lima Pereira Bueno, Mary Ann Foglio, Paula Baréa, Aline Rufino de Oliveira, Maria Helena Sarragiotto, Sara T Olalla Saad, Fernanda Marconi Roversi

Pharmacological Reports · 2024

DOI: 10.1007/s43440-024-00614-4 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmacological Reports, 2024. Verfasst von Maura Lima Pereira Bueno und 6 weiteren Autor:innen. Beteiligte Einrichtung: Hematology and Transfusion Medicine Center, University of Campinas/Hemocentro-UNICAMP, Rua Carlos Chagas, 480 - Cidade Universitária Zeferino Vaz - B…. Hauptthemen laut MEDLINE: Carbolines, Leukemia, Myeloid, Acute, Reactive Oxygen Species, Antineoplastic Agents. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: Fundação de Amparo à Pesquisa do Estado de São Paulo, Conselho Nacional de Desenvolvimento Científico e Tecnológico.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: β-carboline alkaloids exert a distinguished ability to impair cell growth and induce cell death in a variety of cancers and the evaluation of such new therapeutic candidates may denote new possibilities for leukemia treatment. In this present study, we screened 12 β-carboline derivatives containing different substituents at 1- and 3-positions of β-carboline nucleus for their antineoplastic activities in a panel of leukemia cell lines. METHODS: The cytotoxic effects of the β-carboline derivatives were evaluated in different leukemia cell lines as well as reactive oxygen species (ROS) generation, autophagy, and important signaling pathways. RESULTS: Treatment with the β-carboline derivatives resulted in a potent antineoplastic activity leading to a reduced cell viability that was associated with increased cell death in a concentration-dependent manner. Interestingly, the treatment of primary mononuclear cells isolated from the peripheral blood of healthy donors with the β-carboline derivatives showed a minor change in cell survival. The antineoplastic activity occurs by blocking ROS production causing consequent interruption of the PI3K/AKT and MAPK/ERK signaling and modulating autophagy processes. Notably, in vivo, AML burden was diminished in peripheral blood and bone marrow of a xenograft mouse model. CONCLUSIONS: Our results indicated that β-carboline derivatives have an on-target malignant cell-killing activity and may be promising candidates for treating leukemia cells by disrupting crucial events that promote leukemia expansion and chemotherapy resistance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CarbolinesLeukemia, Myeloid, AcuteReactive Oxygen SpeciesAntineoplastic AgentsCell SurvivalXenograft Model Antitumor AssaysHumansAnimalsMiceCell Line, TumorAutophagySignal TransductionDose-Response Relationship, Drug

Stichwörter der Autor:innen

Hematological neoplasmNatural compoundsTreatmentβ-carboline derivatives

Substanzen

CarbolinesReactive Oxygen SpeciesAntineoplastic Agents

Autor:innen und Institutionen

  • Hematology and Transfusion Medicine Center, University of Campinas/Hemocentro-UNICAMP, Rua Carlos Chagas, 480 - Cidade Universitária Zeferino Vaz - Barão Geraldo, Campinas, SP, CEP: 13083-878, Brazil.
  • Faculty of Pharmaceutical Sciences, University of Campinas/UNICAMP, Campinas, SP, Brazil.
  • Department of Chemistry, State University of Maringá, Maringá, PR, Brazil.
  • Hematology and Transfusion Medicine Center, University of Campinas/Hemocentro-UNICAMP, Rua Carlos Chagas, 480 - Cidade Universitária Zeferino Vaz - Barão Geraldo, Campinas, SP, CEP: 13083-878, Brazil. feroversi@gmail.co…
  • Division of Transplantation, Department of Surgery, Emory University, 101 Woodruff Circle, Atlanta, GA, 300322, USA. feroversi@gmail.com.

Förderung

  • Fundação de Amparo à Pesquisa do Estado de São Paulo
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico

Zitieren

APA

Bueno, M. L. P., Foglio, M. A., Baréa, P., de Oliveira, A. R., Sarragiotto, M. H., Saad, S. T. O., & Roversi, F. M. (2024). β-Carboline derivatives are potent against Acute Myeloid Leukemia in vitro and in vivo. Pharmacological Reports. https://doi.org/10.1007/s43440-024-00614-4

Vancouver

Bueno MLP, Foglio MA, Baréa P, de Oliveira AR, Sarragiotto MH, Saad STO, et al. β-Carboline derivatives are potent against Acute Myeloid Leukemia in vitro and in vivo. Pharmacological Reports. 2024. doi:10.1007/s43440-024-00614-4

BibTeX
@article{Bueno2024,
  author = {Bueno, Maura Lima Pereira and Foglio, Mary Ann and Baréa, Paula and de Oliveira, Aline Rufino and Sarragiotto, Maria Helena and Saad, Sara T Olalla and Roversi, Fernanda Marconi},
  title = {β-Carboline derivatives are potent against Acute Myeloid Leukemia in vitro and in vivo},
  journal = {Pharmacological Reports},
  year = {2024},
  doi = {10.1007/s43440-024-00614-4}
}
Kostenlos starten →